Hematologists Accepting First Health in Tennessee

Denise Yardley, M.D.

Hematology

Ian Flinn, M.D.

Hematology

David Portnoy, M.D.

Assistant Professor, Medicine-Hematology, University of Tennessee Health Science Center College of Medicine

Hematology

Navneet Majhail, MD

Director, Sarah Cannon Transplant and Cellular Therapy Program; Deputy Physician-in-Chief, Blood Cancers, Sarah Cannon

Hematology

Gina Vaccaro, M.D.

Hematology

Joseph Merriman, M.D.

Hematology

Katherine Walsh, M.D.

Associate Professor of Medicine, Division of Hematology and Oncology, Vanderbilt University School of Medicine

Hematology

Kent Shih, M.D.

Director, High-Risk Skin Service, Tennessee Oncology

Hematology

Davey Daniel, MD

Chief Medical Officer, OneOncology

Hematology

Erika Hamilton, M.D.

Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute

Hematology

Sonya Reid, MD

Assistant Professor of Medicine, Hematology/Oncology

Hematology

Raymond Osarogiagbon, MD

Director, Multidisciplinary Thoracic Oncology Program

Hematology

Meredith McKean, M.D.

Hematology

Alan Tan, M.D.

Associate Professor of Medicine, Division of Hematology and Oncology

Hematology

Robert Cornell, MD

Assistant Professor of Medicine, Vanderbilt University School of Medicine; Clinical Director of Plasma Cell Disorders, Vanderbilt-Ingram Cancer Center

Hematology

Tamjeed Ahmed, M.D.

Hematology

Donald Gravenor, M.D.

Director, Cancer Committee and Clinical Trials Committee, Baptist Cancer Center

Hematology

Benjamin Garmezy, MD

Director of Genitourinary Research for Sarah Cannon Research Institute at SCRI Oncology Partners

Hematology

Thomas Ratliff, MD

Assistant Professor, Medicine-Hematology, University of Tennessee Health Science Center College of Medicine

Hematology

Jill Gilbert, MD

Professor of Medicine (Hematology/Oncology); Director, Hematology/Oncology Fellowship Program

Hematology